Model predicting the ypN0 status after good response to chemoradiotherapy in rectal cancer

被引：3
|
作者：
Dumont, E. [1 ]
Dartigues, P. [2 ]
Delga, B. [1 ]
Thibaudeau, E. [1 ]
Benhaim, L. [3 ]
Campion, L. [4 ]
Mosnier, J. F. [5 ]
Raimbourg, J. [6 ]
Kerdraon, O. [7 ]
Goere, D. [3 ]
机构：
[1] West Oncol Inst, Dept Digest Oncol Surg, St Herblain, France
[2] Gustave Roussy Canc Campus, Dept Pathol, Villejuif, France
[3] Gustave Roussy Canc Campus, Dept Digest Oncol Surg, Villejuif, France
[4] West Oncol Inst, Dept Stat, St Herblain, France
[5] Univ Hosp, Dept Pathol, Nantes, France
[6] West Oncol Inst, Dept Oncol, St Herblain, France
[7] West Oncol Inst, Dept Pathol, St Herblain, France
来源：
AMERICAN JOURNAL OF SURGERY | 2018年 / 216卷 / 03期
关键词：
Rectal cancer; Chemoradiotherapy; Nodal staging; Lymph node; Chemoradiotherapy T status; Good response; PATHOLOGICAL COMPLETE RESPONSE; LYMPH-NODE METASTASES; PREOPERATIVE CHEMORADIATION; NEOADJUVANT CHEMORADIOTHERAPY; RANDOMIZED-TRIAL; LOCAL EXCISION; METAANALYSIS; CARCINOMA; THERAPY; OXALIPLATIN;
D O I：
10.1016/j.amjsurg.2018.03.025
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
Background: The purpose of this study was to identify the predictive factors for ypN0 status in tumors with good pathologic response to chemoradiotherapy (CRT). Methods: A retrospective chart review was conducted on patients at two tertiary cancer center who underwent rectal resection after good response to CRT between 2000 and 2013. Results: No preoperative treatment (oxaliplatin use, radiotherapy boost of 5,4 Gy, delay CRT-surgery) impacted on the ypN status. In the multivariate analysis, only a ypT<3 (HR 7.5 [2,9-19.5]) was significant and no lymphovascular invasion (HR 8,9 [1.6-49.8]) was limited to significance.The best model predicting the ypN0 status used only the ypT status<3. The major part (92.2%) of patients with ypT0-2 tumors had no LN invasion. Conclusion: The risk of lymph node involvement metastases was only 7.8% for the patients with an ypT0-2 status. A fullthickness transanal resection coud be the futur treatment of these patients. (C) 2018 Elsevier Inc. All rights reserved.
引用
收藏
页码：438 / 443
页数：6
相关论文
共 50 条
  • [31] The assessment of risk factors for long-term survival outcome in ypN0 patients with rectal cancer after neoadjuvant therapy and radical anterior resection
    Marcin Zeman
    Marek Czarnecki
    Ewa Chmielik
    Adam Idasiak
    Władysław Skałba
    Mirosław Strączyński
    Piotr J. Paul
    Agnieszka Czarniecka
    World Journal of Surgical Oncology, 19
  • [32] The assessment of risk factors for long-term survival outcome in ypN0 patients with rectal cancer after neoadjuvant therapy and radical anterior resection
    Zeman, Marcin
    Czarnecki, Marek
    Chmielik, Ewa
    Idasiak, Adam
    Skalba, Wladyslaw
    Straczynski, Miroslaw
    Paul, Piotr J.
    Czarniecka, Agnieszka
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2021, 19 (01)
  • [33] A Multigene Model for Predicting Tumor Responsiveness After Preoperative Chemoradiotherapy for Rectal Cancer
    Cho, Eunhae
    Park, In Ja
    Yeom, Seung-Seop
    Hong, Seung Mo
    Lee, Jung Bok
    Kim, Yeon Wook
    Kim, Mi-Ju
    Lim, Hye Min
    Lim, Seok-Byung
    Yu, Chang Sik
    Kim, Jin Cheon
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (04): : 834 - 842
  • [34] The role of postmastectomy radiation in patients with ypN0 breast cancer after neoadjuvant chemotherapy: a meta-analysis
    Ke Wang
    Xiaoyan Jin
    Weilan Wang
    Xiuyan Yu
    Jian Huang
    BMC Cancer, 21
  • [35] Systematic analysis of parameters predicting pathological axillary status (ypN0 vs. ypN+) in patients with breast cancer converting from cN+ to ycN0 through primary systemic therapy (PST)
    C. Liedtke
    Hans-Christian Kolberg
    L. Kerschke
    D. Görlich
    I. Bauerfeind
    T. Fehm
    B. Fleige
    G. Helms
    A. Lebeau
    A. Stäbler
    S. Schmatloch
    M. Hausschild
    L. Schwentner
    Gunter von Minckwitz
    S. Loibl
    M. Untch
    T. Kühn
    Clinical & Experimental Metastasis, 2018, 35 : 777 - 783
  • [36] ypN0: Does It Matter How You Get There? Nodal Downstaging in Esophageal Cancer
    Andrea Zanoni
    Giuseppe Verlato
    Simone Giacopuzzi
    Massimiliano Motton
    Francesco Casella
    Jacopo Weindelmayer
    Elena Ambrosi
    Alberto Di Leo
    Antonios Vassiliadis
    Francesco Ricci
    Thomas W. Rice
    Giovanni de Manzoni
    Annals of Surgical Oncology, 2016, 23 : 998 - 1004
  • [37] ypN0: Does It Matter How You Get There? Nodal Downstaging in Esophageal Cancer
    Zanoni, Andrea
    Verlato, Giuseppe
    Giacopuzzi, Simone
    Motton, Massimiliano
    Casella, Francesco
    Weindelmayer, Jacopo
    Ambrosi, Elena
    Di Leo, Alberto
    Vassiliadis, Antonios
    Ricci, Francesco
    Rice, Thomas W.
    de Manzoni, Giovanni
    ANNALS OF SURGICAL ONCOLOGY, 2016, 23 : S998 - S1004
  • [38] The role of postmastectomy radiation in patients with ypN0 breast cancer after neoadjuvant chemotherapy: a meta-analysis
    Wang, Ke
    Jin, Xiaoyan
    Wang, Weilan
    Yu, Xiuyan
    Huang, Jian
    BMC CANCER, 2021, 21 (01)
  • [39] Systematic analysis of parameters predicting pathological axillary status (ypN0 vs. ypN+) in patients with breast cancer converting from cN+ to ycN0 through primary systemic therapy (PST)
    Liedtke, C.
    Kolberg, Hans-Christian
    Kerschke, L.
    Goerlich, D.
    Bauerfeind, I.
    Fehm, T.
    Fleige, B.
    Helms, G.
    Lebeau, A.
    Staebler, A.
    Schmatloch, S.
    Hausschild, M.
    Schwentner, L.
    von Minckwitz, Gunter
    Loibl, S.
    Untch, M.
    Kuehn, T.
    CLINICAL & EXPERIMENTAL METASTASIS, 2018, 35 (08) : 777 - 783
  • [40] Clinical parameters predicting pathologic tumor response after preoperative chemoradiotherapy for rectal cancer
    Yoon, Sang Min
    Kim, Dae Yong
    Kim, Tae Hyun
    Jung, Kyung Hae
    Chang, Hee Jin
    Koom, Woong Sub
    Lim, Seok-Byung
    Cho, Hyo Seong
    Jeong, Seung-Yong
    Park, Jae-Gahb
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (04): : 1167 - 1172
12345